TXNRD1
Thioredoxin reductase 1, cytoplasmic
Also known as: GRIM-12, Trxr1, TRXR1_HUMAN, TXNR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16881
- Gene
- TXNRD1
- Ensembl
- ENSG00000198431
- Chromosome
- 12
- Canonical length
- 649 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes an ubiquitously expressed, cytosolic form of TrxR, which functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternative splicing, primarily at the 5' end, results in transcript variants encoding same or different isoforms, including a glutaredoxin-containing isoform that is predominantly expressed in testis. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
649 residues, UniProt reviewed canonical sequence.
>Q16881|TXNRD1
1 MGCAEGKAVA AAAPTELQTK GKNGDGRRRS AKDHHPGKTL PENPAGFTST ATADSRALLQ
61 AYIDGHSVVI FSRSTCTRCT EVKKLFKSLC VPYFVLELDQ TEDGRALEGT LSELAAETDL
121 PVVFVKQRKI GGHGPTLKAY QEGRLQKLLK MNGPEDLPKS YDYDLIIIGG GSGGLAAAKE
181 AAQYGKKVMV LDFVTPTPLG TRWGLGGTCV NVGCIPKKLM HQAALLGQAL QDSRNYGWKV
241 EETVKHDWDR MIEAVQNHIG SLNWGYRVAL REKKVVYENA YGQFIGPHRI KATNNKGKEK
301 IYSAERFLIA TGERPRYLGI PGDKEYCISS DDLFSLPYCP GKTLVVGASY VALECAGFLA
361 GIGLDVTVMV RSILLRGFDQ DMANKIGEHM EEHGIKFIRQ FVPIKVEQIE AGTPGRLRVV
421 AQSTNSEEII EGEYNTVMLA IGRDACTRKI GLETVGVKIN EKTGKIPVTD EEQTNVPYIY
481 AIGDILEDKV ELTPVAIQAG RLLAQRLYAG STVKCDYENV PTTVFTPLEY GACGLSEEKA
541 VEKFGEENIE VYHSYFWPLE WTIPSRDNNK CYAKIICNTK DNERVVGFHV LGPNAGEVTQ
601 GFAAALKCGL TKKQLDSTIG IHPVCAEVFT TLSVTKRSGA SILQAGCUGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TXNRD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 138 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 138 nTPM
- urinary bladder: 130 nTPM
- blood vessel: 83 nTPM
- skeletal muscle: 63 nTPM
- heart muscle: 62 nTPM
- tongue: 60 nTPM
Single-cell type
- ocular epithelial cells: 923 nCPM
- epididymal basal cells: 806 nCPM
- gastric chief cells: 699 nCPM
- foveolar cells: 572 nCPM
- epididymal clear cells: 553 nCPM
- neutrophils: 550 nCPM
Immune cell
- basophil: 110 nTPM
- neutrophil: 103 nTPM
- eosinophil: 70 nTPM
- non-classical monocyte: 49 nTPM
- myeloid DC: 40 nTPM
- intermediate monocyte: 39 nTPM
Brain region
- medulla oblongata: 102 nTPM
- choroid plexus: 68 nTPM
- pons: 60 nTPM
- hypothalamus: 53 nTPM
- midbrain: 45 nTPM
- white matter: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.47
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- FAD binding
- identical protein binding
- thioredoxin-disulfide reductase (NADPH) activity
- NADPH peroxidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutaredoxin
- Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
- Thioredoxin/glutathione reductase selenoprotein
- Pyridine nucleotide-disulphide oxidoreductase, class I, active site
- FAD/NAD-linked reductase, dimerisation domain superfamily
- FAD/NAD(P)-binding domain
- FAD/NAD(P)-binding domain superfamily
- Thioredoxin-like superfamily
- Glutathione reductase/thioredoxin reductase-like
- Glutaredoxin
- Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain
- Pyridine nucleotide-disulphide oxidoreductase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TXNRD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TXNRD1 as an antibody target. Whether an autoantibody or antibody against TXNRD1 could matter depends on whether native TXNRD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TXNRD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TXNRD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...